Actively Recruiting
Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis
Led by University Health Network, Toronto · Updated on 2026-05-01
128
Participants Needed
1
Research Sites
184 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for pathological diagnosis compared to the conventional Menghini-type needle.
CONDITIONS
Official Title
Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 years or older
- Enlarged mediastinal and/or hilar lymph nodes (10 mm or larger on CT scan)
- Suspected sarcoidosis based on clinical history, physical exam, and other investigations
- Scheduled for endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)
You will not qualify if you...
- Unable to provide informed consent
- Lymph node enlargement strongly suspected to be caused by other diseases such as lung cancer, lymphoma, or infection based on clinical history, physical exam, or other investigations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Toronto General Hospital
Toronto, Ontario, Canada, M5G 1L7
Actively Recruiting
Research Team
J
Judy McConnell
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here